Healthcare provider profile · identity verified

Steven Vinay Pinto, MD

Internal Medicine · ANDOVER, NY · NPI 1689109720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	258	90
Atorvastatin Calcium	Atorvastatin Calcium	255	95
Omeprazole	Omeprazole	246	84
Levothyroxine Sodium	Levothyroxine Sodium	221	77
Rosuvastatin Calcium	Rosuvastatin Calcium	219	70
Albuterol Sulfate Hfa	Albuterol Sulfate	211	64
Amlodipine Besylate	Amlodipine Besylate	208	76
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	189	39
Metoprolol Succinate	Metoprolol Succinate	181	68
Furosemide	Furosemide	179	64
Gabapentin	Gabapentin	165	53
Metformin Hcl	Metformin Hcl	163	52
Trazodone Hcl	Trazodone Hcl	122	32
Tramadol Hcl	Tramadol Hcl	109	24
Duloxetine Hcl	Duloxetine Hcl	102	29
Tamsulosin Hcl	Tamsulosin Hcl	98	31
Alprazolam	Alprazolam	96	27
Pantoprazole Sodium	Pantoprazole Sodium	94	44
Hydrochlorothiazide	Hydrochlorothiazide	92	32
Famotidine	Famotidine	89	35
Eliquis	Apixaban	86	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	30
Simvastatin	Simvastatin	80	29
Montelukast Sodium	Montelukast Sodium	77	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	17
Losartan Potassium	Losartan Potassium	71	25
Sertraline Hcl	Sertraline Hcl	67	24
Glipizide	Glipizide	65	20
Meclizine Hcl	Meclizine Hcl	64	26
Metformin Hcl Er	Metformin Hcl	61	22
Pravastatin Sodium	Pravastatin Sodium	59	21
Diazepam	Diazepam	58	suppressed
Pregabalin	Pregabalin	58	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	21
Azithromycin	Azithromycin	57	46
Fluoxetine Hcl	Fluoxetine Hcl	57	18
Oxycodone Hcl	Oxycodone Hcl	57	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	43
Januvia	Sitagliptin Phosphate	56	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	54	25
Metoprolol Tartrate	Metoprolol Tartrate	53	20
Amitriptyline Hcl	Amitriptyline Hcl	52	15
Potassium Chloride	Potassium Chloride	52	20
Escitalopram Oxalate	Escitalopram Oxalate	50	17
Ropinirole Hcl	Ropinirole Hcl	50	13
Ozempic	Semaglutide	49	11
Alendronate Sodium	Alendronate Sodium	47	15
Fluticasone Propionate	Fluticasone Propionate	47	21
Meloxicam	Meloxicam	47	20
Ezetimibe	Ezetimibe	46	18
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Spironolactone	Spironolactone	43	15
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	14
Clonazepam	Clonazepam	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	13
Celecoxib	Celecoxib	35	11
Finasteride	Finasteride	34	11
Bupropion Xl	Bupropion Hcl	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	15
Pioglitazone Hcl	Pioglitazone Hcl	31	13
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Torsemide	Torsemide	31	12
Buspirone Hcl	Buspirone Hcl	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	12
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Xarelto	Rivaroxaban	29	suppressed
Carisoprodol	Carisoprodol	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	12
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	21
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Ondansetron Odt	Ondansetron	26	11
Topiramate	Topiramate	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Levofloxacin	Levofloxacin	25	23
Loperamide	Loperamide Hcl	25	suppressed
Sucralfate	Sucralfate	25	11
Baclofen	Baclofen	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Fentanyl	Fentanyl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Clotrimazole	Clotrimazole	21	suppressed
Naproxen	Naproxen	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Fluconazole	Fluconazole	20	14
Zaleplon	Zaleplon	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Prednisone	Prednisone	18	13
Rybelsus	Semaglutide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Epinephrine	Epinephrine	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Metronidazole	Metronidazole	15	12
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nyamyc	Nystatin	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lidocaine	Lidocaine	12	11
Olanzapine	Olanzapine	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Nystatin	Nystatin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error